Business Description
Mydecine Innovations Group Inc
NAICS : 325411
SIC : 3741
ISIN : CA62849F2008
Description
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -98.01 | |||||
| Debt-to-Equity | -0.37 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 62.1 | |||||
| 3-Year EPS without NRI Growth Rate | 55.4 | |||||
| 3-Year FCF Growth Rate | 65.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -145.9 | |||||
| Shareholder Yield % | -179.88 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1194.21 | |||||
| ROIC % | -143.85 | |||||
| 3-Year ROIIC % | -30.68 | |||||
| ROC (Joel Greenblatt) % | -1077300 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.66 | |||||
| EV-to-EBITDA | -0.66 | |||||
| EV-to-FCF | -20.25 | |||||
| Earnings Yield (Greenblatt) % | -150.5 | |||||
| FCF Yield % | -56.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mydecine Innovations Group Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.128 | ||
| Beta | 0 | ||
| Volatility % | 30 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (£) | 0.000007 | ||
| 20-Day SMA (£) | 0.0175 | ||
| 12-1 Month Momentum % | -30 | ||
| 52-Week Range (£) | 0.0175 - 0.025 | ||
| Shares Outstanding (Mil) | 61.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mydecine Innovations Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mydecine Innovations Group Inc Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mydecine Innovations Group Inc Frequently Asked Questions
What is Mydecine Innovations Group Inc(AQSE:MYIG)'s stock price today?
The current price of AQSE:MYIG is £0.02. The 52 week high of AQSE:MYIG is £0.03 and 52 week low is £0.02.
When is next earnings date of Mydecine Innovations Group Inc(AQSE:MYIG)?
The next earnings date of Mydecine Innovations Group Inc(AQSE:MYIG) is .
Does Mydecine Innovations Group Inc(AQSE:MYIG) pay dividends? If so, how much?
Mydecine Innovations Group Inc(AQSE:MYIG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers